Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erwan Arzel is active.

Publication


Featured researches published by Erwan Arzel.


Bioorganic & Medicinal Chemistry Letters | 2010

Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques

Britt-Marie Swahn; David Wensbo; Johan Sandell; Daniel Sohn; Can Slivo; David Pyring; Jonas Malmström; Erwan Arzel; Michaela Vallin; Margareta Bergh; Fredrik Jeppsson; Allan E. Johnson; Anders Juréus; Jan Neelissen; Samuel P.S. Svensson

The syntheses and SAR of new series of beta-amyloid binding agents are reported. The effort to optimize signal-to-background ratios for these ligands are described. Compounds 8, 21 and 30 displayed desirable lipophilicity and pharmacokinetic properties. Compounds 8 and 21 were evaluated with in vitro autoradiographic studies and in vivo in APP/PS1 transgenic mice. It is shown that it was possible to increase the signal-to-background ratios compared to PIB 1, as demonstrated by compounds 8 and 21.


Bioorganic & Medicinal Chemistry Letters | 2006

Design and synthesis of 2'-anilino-4,4'-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3.

Britt-Marie Swahn; Yafeng Xue; Erwan Arzel; Elisabet Kallin; Angelika Magnus; Niklas Plobeck; Jenny Viklund


Archive | 2006

New compounds ii

Per I. Arvidsson; Erwan Arzel; Jeremy N. Burrows; Helena Gyback; Tobias Rein; Didier Rotticci; Peter Söderman


Archive | 2006

Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders

Per I. Arvidsson; Erwan Arzel; Jeremy N. Burrows; Martina Claesson; Colin Ray; Tobias Rein; Didier Rotticci; Peter Söderman


Archive | 2006

New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease

Lars I. Andersson; Erwan Arzel; Stefan Berg; Jeremy N. Burrows; Sven Hellberg; Fernando Huerta; Torben Pedersen; Tobias Rein; Didier Rotticci; Karin Staaf


Archive | 2004

Novel pyridine derivatives as jnk specific inhibitors

Niklas Plobeck; Britt-Marie Swahn; Erwan Arzel


Archive | 2008

Tetrazole derivatives as modulators of metabotropic glutamate receptors (mglurs)

Erwan Arzel; Louise Edwards; Methvin Isaac; Donald Mcleod; Abdelmalik Slassi; Tao Xin


Archive | 2008

2-heteroaryl substituted benzothiophenes and benzofuranes 709

Erwan Arzel; Britt-Marie Swahn; David Wensbo


Archive | 2006

Acetylenic piperazines as metabotropic glutamate receptor antagonists

Louise Edwards; Methvin Isaac; Abdelmalik Slassi; Guang-Ri Sun; Peter Dove; Erwan Arzel


Archive | 2009

New compounds 067

Erwan Arzel; Louise Edwards; Methvin Isaac; Donald A. Mcleod; Abdelmalik Slassi; Tao Xin

Collaboration


Dive into the Erwan Arzel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Louise Edwards

University Health Network

View shared research outputs
Top Co-Authors

Avatar

Methvin Isaac

Ontario Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge